Direct answer: A residual-solvent statement is useful only when it identifies relevant solvents, the analytical method, reporting units, acceptance criteria and the actual lot. Pharmaceutical ICH limits are context-specific and must not be copied onto unrelated research or cosmetic materials as a universal standard.
Technical editorial review: 22 October 2026. Confirm current standards, market rules and batch records before purchase.
Start with the solvents relevant to the manufacturing route
Residual solvents are volatile organic chemicals that may be used or produced during manufacture or purification and may remain after processing. The first procurement question is therefore which solvents are relevant to the offered route, not whether a generic “solvent-free” badge appears on a product page. ICH Q3C(R9) recommends limits and solvent classes for pharmaceutical drug substances, excipients and products in its stated scope. It says testing is relevant when manufacture or purification is known to introduce a solvent; it does not create a universal acceptance limit for every research or cosmetic catalog item. Ask the supplier for a route-based solvent list, the specification applied to the intended market and a current-lot result where the risk assessment calls for testing. A declaration that no named solvent was used should be traceable to process records. Do not infer absence of all possible solvents from one chromatogram or from a single line on a sample certificate.
Route-aware request fields
- Solvents used or generated in the relevant processing steps
- Which solvents were selected for testing and why
- Method, detection capability and reporting units
- Acceptance criterion and its project-specific basis
- Actual lot result and any justified exception
Read a result against its method and decision rule
A report may use ppm, mg/kg, percentage or another basis. The number is meaningful only alongside the tested material form, method and applicable acceptance rule. Ask whether a result below the reporting limit means “not detected” under that method or whether the laboratory has measured a numerical concentration. Check that sample lot, test date and material form match the proposed shipment. If the buyer’s application has a formal pharmaceutical limit, review the current ICH Q3C version and local requirements with the appropriate quality and regulatory team; a cosmetic or research-use project may need a different justified specification. A supplier may use a risk assessment rather than test every lot for every possible solvent, but the rationale should be documented and reviewable. Keep the analytical report, route assessment and signed product specification together so that later changes to process or packaging can trigger a new review.
Questions to resolve before release
- Is the reported unit and material basis explicit?
- Does “below limit” identify the actual method limit?
- Does the lot on the report match the label and COA?
- Was a process change assessed for new solvent risk?
Avoid transferring pharmaceutical limits without context
ICH Q3C is often cited in catalog conversations because its classifications are familiar, but its stated purpose is patient safety in pharmaceuticals. The webpage for a peptide raw material should say which intended-use category is being discussed and whether a regulatory guideline is directly applicable, used as a comparison, or outside the project scope. For cosmetic ingredients, the brand or responsible party must evaluate product safety under the rules of the target market; the raw-material supplier can provide composition and quality information, but it cannot determine final-product compliance from an isolated solvent result. For research-use materials, a buyer can still set measurable solvent criteria in a purchase specification without claiming pharmaceutical approval. Send the target market, material form and required tests through the RFQ form, then connect the answer to the batch documentation discussed in Quality & Compliance. This preserves the distinction between a useful analytical reference and a binding release requirement.
Use-category boundary
- Pharmaceutical: apply relevant current rules and registered specifications
- Cosmetic: evaluate ingredient and finished-product safety for the market
- Research: agree a fit-for-purpose specification and documentation
Frequently asked questions
Does “not detected” mean zero solvent?
No. It means the method did not report the analyte above its stated detection or reporting threshold.
Does ICH Q3C automatically apply to every peptide?
No. It addresses residual solvents in specified pharmaceutical contexts; the applicable standard depends on the project.
What should accompany a solvent result?
Request the lot, material form, method, units, tested analytes, reporting limits and acceptance criteria.
References and scope
These primary sources define the cited concepts. Regulatory guidelines apply only within their stated scope; this article provides buyer questions and does not certify a particular material or lot.
Related: product catalog · quality review · all resources · request a project quote.